Mor­phoSys’ chief sci­en­tist hits the ex­it, trig­ger­ing R&D re­or­ga­ni­za­tion as they shift fo­cus to US in an­tic­i­pa­tion of loom­ing FDA ap­proval

Just a few days af­ter open­ing up its new US head­quar­ters on Boston har­bor in prep for what they be­lieve is the im­mi­nent ap­proval of a new CAR-T ri­val, Mor­phoSys says that its top sci­en­tist is step­ping down and they’re re­or­ga­niz­ing R&D un­der de­vel­op­ment chief Malte Pe­ters.

We don’t know the de­tails about what’s up, aside from the fact that they said in an an­nounce­ment that 17-year com­pa­ny vet­er­an Markus En­zel­berg­er is leav­ing his job as chief sci­en­tif­ic of­fi­cer to ex­plore new op­por­tu­ni­ties. And with his de­par­ture, they will be “in­te­grat­ing” re­search in­to the de­vel­op­ment op­er­a­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER